Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA sequence analysis to compare MMTV-PyMT tumor cells with and without Dll1

ABSTRACT: Several cell cycle genes were altered between Dll1+ and Dll1- population of tumor cells

ORGANISM(S): Mus musculus

PROVIDER: GSE129198 | GEO | 2020/11/20

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

ATAC sequence analysis to compare MMTV-PyMT tumor cells with and without Dll1

Project description:Several genes like Nfkb, Npy and Dll1 showed altered enrichment peaks between Dll1+ and Dll1- population of tumor cells.

2020-11-20 | GSE133736 | GEO

ATAC sequence analysis to compare MMTV-PyMT tumor cells with and without Dll1

Project description:ATAC sequence analysis to compare MMTV-PyMT tumor cells with and without Dll1

| PRJNA552361 | ENA

RNA sequence analysis to compare MMTV-PyMT tumor cells with and without Dll1

Project description:RNA sequence analysis to compare MMTV-PyMT tumor cells with and without Dll1

| PRJNA530514 | ENA

RNA sequence analysis to compare MCF7 Tamoxifen resistant cells with and without DLL1

Project description:Several signatures including Tgb pathway, cytokines, Notch signaling is altered whe DLL1 is reduced

2023-01-20 | GSE143989 | GEO

RNA sequence analysis to compare Dll1+ mouse breast tumor cells with and without targeted radiation

Project description:Data generrated shows that Dll1 has several genes upregulated after targeted radiation at day 30 inlcuding EMT, ROS etc

2022-04-20 | GSE172398 | GEO

RNA sequence analysis to compare Dll1+ mouse breast tumor cells with and without targeted radiation

Project description:RNA sequence analysis to compare Dll1+ mouse breast tumor cells with and without targeted radiation

| PRJNA723221 | ENA

RNA sequence analysis to compare MCF7 Tamoxifen resistant cells with and without DLL1

Project description:RNA sequence analysis to compare MCF7 Tamoxifen resistant cells with and without DLL1

| PRJNA602464 | ENA

Dll1 dependent heterogeneity of tumor and cancer fibroblasts

Project description:To survey the diverse tumor cell populations of aggressive luminal breast cancer (non-TNBC) at a cellular level, we utilized Dll1+ and Dll1- tumors from a recently published PyMT-Dll1mCherry reporter breast cancer mouse model.

2022-08-14 | GSE182011 | GEO

Oncoprotein GT198 vaccination delays tumor growth in MMTV-PyMT mice.

Project description:Targeting early lesion in breast cancer is more therapeutically effective. We have previously identified an oncoprotein GT198 (PSMC3IP) in human breast cancer. Here we investigated GT198 in MMTV-PyMT mouse mammary gland tumors and found that GT198 is a shared early lesion in both species. Similar to human breast cancer even before a tumor appears, cytoplasmic GT198 is overexpressed in mouse tumor stroma including pericyte stem cells, descendent adipocytes, fibroblasts, and myoepithelial cells. Using recombinant GT198 protein as an antigen, we vaccinated MMTV-PyMT mice and found that the GT198 vaccine delayed mouse tumor growth and reduced lung metastasis. The antitumor effects were linearly correlated with vaccinated mouse serum titers of GT198 antibody, which recognized cell surface GT198 protein on viable tumor cells confirmed by FACS. Furthermore, GT198+ tumor cells isolated from MMTV-PyMT tumor induced faster tumor growths than GT198- cells when re-implanted into normal FVB/N mice. Together, this first study of GT198 vaccine in mouse showed its effectiveness in antitumor and anti-metastasis. The finding supports GT198 as a potential target in human immunotherapy since GT198 defect is shared in both human and mouse.

| S-EPMC7067666 | biostudies-literature

Dll1 acts as a tumor suppressor in neural stem cells to induce an astroglial lineage-restricted glioblastoma

Project description:There is increasing evidence for tissue stem cells as potential source for cancers. However, the cellular and molecular mechanisms at the origin of this transformation remain elusive. Here we show that Delta-like1 (Dll1) mutation induces the oncogenic transformation of neural stem cell–derived neurospheres into oncogenic spheres capable of generating histological and molecular human glioblastoma (GBM)-like tumors upon subcutaneous and intracranial transplantations into nude mice. Serial transplantation assays suggest that Dll1 spheres tumorigenicity results from the oncogenic transformation of normal neural stem cell into GBM-producing stem cell. Compared differentiation of Dll1 vs. WT spheres shows the presence in Dll1 spheres of a subpopulation of cells which although fated to a glial lineage fail to differentiate terminally, in keeping with the astrocytic promoting function of Delta-Notch. This population of astrocyte progenitors proliferates actively and fails to down-regulate EGFR phosphorylation. These studies suggest that Dll1-induced tumorigenesis is restricted to the astrocytic lineage thereby providing a model for human GBM as well as an explanation for the duality of Notch signaling acting either as an oncogene or a tumor suppressor in stem/progenitor cells derived tumors, depending on the lineage commitment. Comparison between control (WT) and mutants (Dll1-3 and Dll1-5) cells was performed. Two biological replicates (n=3 each replicate) were used, and each replicate (n=3, total RNA pooled) was dye-swaped.

2011-09-23 | E-GEOD-32293 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data